Close

Press Releases

UBM to Launch Southeast Asia’s Leading International Beauty Trade Show In Thailand

BANGKOK Feb. 25 2014 - UBM Asia is pleased to announce the launch of ASEANbeauty the only beauty trade event supported by the Thai Cosmetics Manufacturers Association. This is to be the premier international beauty trade show for South...

The Most Complete Information on America’s Nursing Facilities

WASHINGTON: U.S. News & World Report publisher of Best Hospitals and Best Children's Hospitals today released its Best Nursing Homes 2014 highlighting the top nursing homes in every state and nearly 100 major metropolitan areas. Now in its sixth year...

NBE-Therapeutics Announces Successful Validation of its SMAC™-Technology for the Generation of Antibody Drug Conjugates (ADCs)

Basel, Switzerland, February 21, 2014 - NBE-Therapeutics (“NBE”) today announced that it has presented the successful validation of its enzymatic SMAC™-Technology for the generation of potent next-generation antibody drug conjugates (ADCs) at the international World ADC summit 2014 in...

Domain Therapeutics enters into collaboration with XOMA

DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Strasbourg, France, February 4, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today...

Cellectis grants genOway an exclusive sublicense for its homologous recombination technology in the field of genetically modified rodent models

The agreement covers the creation and sale of rodent animal models, the sale of existing rodent animal models and sublicensing rightsParis, France, February 4, 2014 – Cellectis (Alternext: ALCLS), the genome engineering specialist, and genOway (Alternext: ALGEN), the animal...

TxCell to present an innovative, personalized cell-based immunotherapy approach at the 16th BIO CEO & Investor Conference 2014, New York, USA

TxCell SA, a clinical stage biotechnology company developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today that Damian Marron, CEO, TxCell, will present at BIO CEO & Investor Conference 2014....

DARA BioSciences enters into pharmacy supply deal with RainTree

US-based pharmaceutical firm dedicated to the commercialization of oncology treatment and oncology supportive care products DARA BioSciences has signed a pharmacy supply agreement with RainTree Oncology Services. The agreement is for both Gelclair,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »